Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

IceCure Medical Reports Final ICE3 Breast Cancer Cryoablation Trial Results; Data Submitted To FDA Requesting Marketing Authorization To Treat Early-Stage Breast Cancer

Author: Benzinga Newsdesk | April 15, 2024 08:37am

Data presentation at highly influential American Society of Breast Surgeons ("ASBrS") Annual Meeting by Dr. Richard Fine wins Scientific Impact Award as voted by breast surgeons
President-Elect of the ASBrS, Dr. Michael Berry, presents data and states "cryoablation is ready for prime time"
Company seeks indication for treating women with early stage T1 invasive breast cancer with adjuvant hormone therapy
Available reimbursement code for facility expense expected to enhance usage upon receiving marketing authorization
Minimally-invasive ProSense® cryoablation offers highly favorable healthcare economics

Posted In: ICCM